posted on 2017-08-23, 09:37authored byDavid J. Cousins
A new proinflammatory subtype of antigen-specific T H 2 cell that expresses CD161 emerges as the pathogenic cell type in allergic disease and is deleted during allergen-specific immunotherapy (Wambre et al., this issue).
Funding
DJC has received research grant funding from Asthma UK, Medical Research Council, BBSRC,
GSK, MedImmune, Midlands Asthma and Allergy Research Association and the NIHR
Leicester Biomedical Research Centre.
History
Citation
Science Translational Medicine, 2017, 9 (401)
Author affiliation
/Organisation/COLLEGE OF MEDICINE, BIOLOGICAL SCIENCES AND PSYCHOLOGY/School of Medicine/Department of Infection, Immunity and Inflammation
Version
AM (Accepted Manuscript)
Published in
Science Translational Medicine
Publisher
American Association for the Advancement of Science